Biotech

German biotech firm explores hospital-linked cell and gene therapy manufacturing in India while assessing long-term opportunities in regional CGT production, training and exports

India AI Impact Summit 2026: Kiran Mazumdar-Shaw said India must build biotech sovereignty powered by AI to protect health security and lead the future of medicine

Antique expects the Concord to report revenue, Ebitda and PAT CAGR of 18 per cent, 17 per cent and 19 per cent, respectively, with margins remaining stable at around 42 per cent over FY25-28E

With a record wave of deal-making, IPO activity and fresh venture capital flowing into Chinese biotech in 2024-25, prices of lab monkeys used for drug testing are rising again

SC's decision to close criminal proceedings against the Sandesara brothers after a substantial repayment has raised concerns that other high-profile economic offenders may seek similar settlements

Kiran Mazumdar-Shaw urges India to achieve 'biotech sovereignty' by 2047, driven by a $330 bn bioeconomy, BioE3 framework, scale exports, a sovereign AI stack, and crucial R&D investment

As regulators ease biosimilar trial norms, Syngene International is expanding into late-stage clinical supply production, betting on biologics and peptide manufacturing for growth

In-space manufacturing uses the near-weightless environment of space to produce materials and products of superior quality

Top regulators like the US FDA and EMA are fast-tracking more Chinese drugs, granting priority review and breakthrough designations as they gain confidence in China's biotech innovation

Hyderabad-based biotech Utopia Therapeutics raises seed funding from Whale Tank to accelerate preclinical work on its novel immunotherapy vaccine targeting obesity

Lilly has struck multiple partnership deals with gene-editing companies in the last two years to expand its portfolio beyond its blockbuster weight-loss and diabetes drugs

The investment is expected to promote innovation and growth, further positioning Telangana as a global hub for emerging industries

Concord Biotech share price rose on the back of a healthy March quarter of financial year 2025 (Q4FY25) results.

The funding will be used to build one of India's largest facilities capable of processing 150 tons of feedstock daily and also expand the scientific team and enter global markets

The Karnataka government and the German state of Bavaria signed a Memorandum of Understanding (MoU) on Tuesday to collaborate in key areas, including Artificial Intelligence, quantum technology, biotechnology, Smart Cities, higher education, and sustainable agriculture, among others. The MoU was signed by Karnataka's Minister for Large and Medium Industries, M B Patil, and Dr Florian Herrmann, Head of the Bavarian State Chancellery. Karnataka's Minister for IT/BT, Priyank Kharge, was also present at the event. Speaking on the occasion, Minister Patil stated that the agreement will remain in effect for five years. As part of the collaboration, the two regions will work together in sectors such as Industry 4.0, space technology, medical technology, green tech, urban infrastructure, skill development, employment generation, entrepreneurship, and cybersecurity, he added. During the meeting, Herrmann was briefed in detail about Karnataka's robust industrial ecosystem and the various ..

According to the report, titled "India Bioeconomy Report 2025", the bioeconomy sector witnessed a 16-fold expansion in the past decade, from $10 billion in 2014 to $165.7 billion in 2024

This initiative reinforces the company's mission to provide deep life sciences-backed, innovative shrimp and fish health and farm care solutions

The Genome India Data, which captures the genetic diversity of India's population, will be available to researchers at the Indian Biological Data Centre (IBDC) through managed access

The scheme aims to refund to exporters the embedded central, state, and local duties and taxes paid on inputs that were so far not refunded or rebated

It is targeting a $100 m inventory improvement by March